natgillin/translations-raw huggingface dataset:
Hver karton indeholder ét type I-hætteglas til éngangsbrug med gummibutylstopper og aluminiumforsegling, der kan vippes af.
Each carton contains one single-use type I glass vial with a rubber butyl stopper and a "flip-off" aluminium seal.
Hver Kovaltry-pakning indeholder et hætteglas med Bio-Set-hætte og en fyldt injektionssprøjte med separat stempelstang samt et venepunktursæt (til injektion i en blodåre).
Each pack of Kovaltry contains a vial and a pre-filled syringe with a separate plunger rod, as well as a vial adapter and a venipuncture set (for injection into a vein).
Hver Kovaltry-pakning indeholder et hætteglas med Bio-Set-hætte og en fyldt injektionssprøjte med separat stempelstang samt et venepunktursæt (til injektion i en blodåre).
Each pack of Kovaltry contains a vial with Bio-Set cap and a pre-filled syringe with a separate plunger rod, as well as a venipuncture set (for injection into a vein).
Hver KwikPen indeholder 300 enheder (3 milliliter).
Each Humalog Mix25 KwikPen contains 300 units (3 millilitres).
Hver Leflunomide Teva 10 mg filmovertrukket tablet indeholder 10 mg leflunomid.
Each Leflunomide Teva 10 mg film-coated tablet contains 10 mg of leflunomide.
Hver Leflunomide Teva 20 mg filmovertrukket tablet indeholder 20 mg leflunomid.
Each Leflunomide Teva 20 mg film-coated tablet contains 20 mg of leflunomide.
Hver leverede dosis (dosis fra mundstykket) indeholder 45 mikrogram salmeterol (som salmeterolxinafoat) og 465 mikrogram fluticasonpropionat.
Each delivered dose (the dose from the mouthpiece) contains 45 micrograms of salmeterol (as salmeterol xinafoate) and 465 micrograms of fluticasone propionate.
Hver leverede dosis (dosis, der forlader mundstykket) indeholder 45 mikrogram salmeterol (som salmeterolxinafoat) og 465 mikrogram fluticasonpropionat.
Each delivered dose (the dose that leaves the mouthpiece) contains 45 micrograms of salmeterol (as salmeterol xinafoate) and 465 micrograms of fluticasone propionate.
Hver leveret dosis (den dosis, der afgives fra mundstykket af inhalatoren) indeholder 110 µg indacaterolmaleat svarende til 85 µg indacaterol og 54 µg glycopyrroniumbromid svarende til 43 µg glycopyrronium.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 110 µg of indacaterol maleate equivalent to 85 µg of indacaterol and 54 µg of glycopyrronium bromide equivalent to 43 µg of glycopyrronium.
Hver leveret dosis (dosen der kommer ud af mundstykket) indeholder 375 µg aclidiniumbromid svarende til 322 µg aclidinium.
Each delivered dose (the dose leaving the mouthpiece) contains 375 µg aclidinium bromide equivalent to 322 µg of aclidinium.
Hver leveret dosis (dosis fra mundstykket) indeholder 45 mikrogram salmeterol (som salmeterolxinafoat) og 465 mikrogram fluticasonpropionat.
Each delivered dose (the dose from the mouthpiece) contains 45 micrograms of salmeterol (as salmeterol xinafoate) and 465 micrograms of fluticasone propionate.
Hver leveret dosis indeholder 396 mikrogram aclidiniumbromid, svarende til 340 mikrogram aclidinium, og 11,8 mikrogram formoterolfumaratdihydrat.
Each delivered dose contains 396 micrograms aclidinium bromide equivalent to 340 micrograms of aclidinium and 11.8 micrograms of formoterol fumarate dihydrate.
Hver Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg tablet indeholder 100 mg levodopa, 25 mg carbidopa og 200 mg entacapon.
Each Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg tablet contains 100 mg of levodopa, 25 mg of carbidopa and 200 mg of entacapone.
Hver Levodopa/Carbidopa/Entacapone Orion 125 mg/31,25 mg/200 mg tablet indeholder 125 mg levodopa, 31,25 mg carbidopa og 200 mg entacapon.
Each Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg tablet contains 125 mg of levodopa, 31.25 mg of carbidopa and 200 mg of entacapone.
Hver Levodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg tablet indeholder 150 mg levodopa, 37,5 mg carbidopa og 200 mg entacapon.
Each Levodopa/Carbidopa/Entacapone Orion 150 mg/37.5 mg/200 mg tablet contains 150 mg of levodopa, 37.5 mg of carbidopa and 200 mg of entacapone.
Hver Levodopa/Carbidopa/Entacapone Orion 175 mg/43,75 mg/200 mg tablet indeholder 175 mg levodopa, 43,75 mg carbidopa og 200 mg entacapon.
Each Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg tablet contains 175 mg of levodopa, 43.75 mg of carbidopa and 200 mg of entacapone.
Hver Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg tablet indeholder 200 mg levodopa, 50 mg carbidopa og 200 mg entacapon.
Each Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg tablet contains 200 mg of levodopa, 50 mg of carbidopa and 200 mg of entacapone.
Hver Levodopa/Carbidopa/Entacapone Orion 50 mg/12,5 mg/200 mg tablet indeholder 50 mg levodopa, 12,5 mg carbidopa og 200 mg entacapon.
Each Levodopa/Carbidopa/Entacapone Orion 50 mg/12.5 mg/200 mg tablet contains 50 mg of levodopa, 12.5 mg of carbidopa and 200 mg of entacapone.
Hver Levodopa/Carbidopa/Entacapone Orion 75 mg/18,75 mg/200 mg tablet indeholder 75 mg levodopa, 18,75 mg carbidopa og 200 mg entacapon.
Each Levodopa/Carbidopa/Entacapone Orion 75 mg/18.75 mg/200 mg tablet contains 75 mg of levodopa, 18.75 mg of carbidopa and 200 mg of entacapone.
Hver Lyxumia-pen indeholder 14 forindstillede doser.
Each Lyxumia pen contains 14 pre-set doses.
Hver matrix indeholder pr. cm2: Human fibrinogen 5,5 mg Human thrombin 2,0 IE
Each matrix contains per cm2 Human fibrinogen 5.5 mg Human thrombin 2.0 IU
Hver medlemsstat skal desuden sikre, at der udleveres informationsmateriale og patientkort til de ordinerende læger og patienterne.
Each Member State will also ensure that educational material and patient cards are provided to prescribers and patients.
Hver medlemsstat vil desuden sikre, at der udleveres informationsmateriale og patientkort til de ordinerende læger og patienterne.
Each Member State will also ensure that educational materials and patient cards are provided to prescribers and patients.
Hver milliliter (ml) af injektionsvæsken, opløsningen indeholder 0,25 miligram (mg) exenatid.
Each millilitre (ml) of the solution for injection contains 0.25 milligrams (mg) of exenatide.
Hver milliliter (ml) vises som et nummer med en stor linie.
Each millilitre (mL) is shown as a number with a big line.
Hver milliliter af opløsningen indeholder 100 enheder af det aktive stof insulin glulisin (svarende til 3,49 mg).
Each ml of the solution contains 100 Units of insulin glulisine (equivalent to 3.49 mg).
Hver milliliter opløsning indeholder 1,850 GBq yttriumchlorid (90Y) kalibreringsdatoen. (GBq: GigaBecquerel er måleenheden for radioaktivitet).
Each millilitre of solution contains 1.850 GBq of Yttrium (90Y) chloride at the date of calibration.(GBq : GigaBecquerel, Becquerel is the unit in which radioactivity is measured).
Hver milliliter Stocrin oral opløsning indeholder 30 mg af det aktive stof efavirenz.
Each ml of Stocrin oral solution contains 30 mg of the active substance efavirenz.
Hver ml af ABILIFY oral opløsning indeholder 200 mg fructose og 400 mg saccharose.
Each ml of ABILIFY oral solution contains 200 mg of fructose and 400 mg of sucrose.
Hver ml af den orale opløsning indeholder 5 mg lamivudin
Each ml of the oral solution contains 5 mg lamivudine.
Hver ml af Emtriva oral opløsning indeholder 10 mg emtricitabin (10 mg/ml).
One ml of Emtriva oral solution contains 10 mg of emtricitabine (10 mg/ml).
Hver ml af infusionsvæsken indeholder 0,05 mg vandfri zoledronsyre (som monohydrat).
Each ml of the solution contains 0.05 mg zoledronic acid (as monohydrate).
Hver ml af mundhulegelen indeholder:
Each ml of the oromucosal gel contains:
Hver ml af opløsningen indeholder 400 MBq flutemetamol (18F) på referencedatoen og –tidspunktet.
Each mL of solution for injection contains 400 MBq of flutemetamol (18F) at reference date and time.
Hver ml af opløsningen indeholder 50 mikrogram palonosetron.
Each ml of solution contains 50 micrograms of palonosetron.
Hver ml af opløsningen indeholder flutemetamol (18F) 400 MBq på referencetidspunktet.
Each mL of solution contains flutemetamol (18F) 400 MBq at reference time.
Hver ml af opløsningen indeholder i alt 100 enheder (E) insulin degludec/insulin aspart i forholdet 70/30.
Each mL of solution contains a total of 100 units (U) insulin degludec/insulin aspart in the ratio 70/30.
Hver ml af rekonstitueret suspension indeholder oseltamivirphosphat svarende til 12 mg oseltamivir.
Each ml of reconstituted suspension contains oseltamivir phosphate equivalent to 12 mg of oseltamivir.
Hver ml indeholder 0,7 mg (0,03 mmol).
Each ml contains 0.7 mg (0.03 mmol).
Hver ml indeholder 0,81 mg ethanol 96 % (svarende til 0,75 mg ethanol).
Each ml contains 0.81 mg ethanol 96% (equivalent to 0.75 mg ethanol)
Hver ml indeholder 1 mg aripiprazol.
Each ml contains 1 mg of aripiprazole.
Hver ml indeholder 1 mg aripiprazol.
Each ml oral solution contains 1 mg of aripiprazole.
Hver ml indeholder 1 mg sirolimus.
Each mL contains 1 mg sirolimus.
Hver ml indeholder 1 mg temoporfin
Each ml contains 1 mg of temoporfin.
Hver ml indeholder 1 mg.
Each ml contains 1 mg.
Hver ml indeholder 1,12 mg cabergolin.
Each ml contains 1.12 mg of cabergoline.
Hver ml indeholder 1,3 mg methylparahydroxybenzoat (E218) og 0,163 mg propylparahydroxybenzoat (E216).
Each ml contains 1.3 mg of methyl parahydroxybenzoate (E218), 0.163 mg of propyl parahydroxybenzoate (E216)
Hver ml indeholder 1,62 mg ethanol 96 % (svarende til 1,50 mg ethanol).
Each ml contains 1.62 mg ethanol 96% (equivalent to 1.50 mg ethanol).
Hver ml indeholder 10 mg brivaracetam.
Each ml contains 10mg brivaracetam
Hver ml indeholder 10 mg emtricitabin.
Each ml contains 10 mg of emtricitabine.
Hver ml indeholder 10 mg mecasermin
Each ml contains 10 mg of mecasermin.
Hver ml indeholder 10 mg rituximab.
Each mL contains 10 mg of rituximab.
Hver ml indeholder 100 enheder insulin glargin (svarende til 3,64 mg)
Each mL contains 100 units insulin glargine (equivalent to 3.64 mg).
Hver ml indeholder 100 enheder insulin glargin (svarende til 3,64 mg)
Each mL contains 100 unitsinsulin glargine (equivalent to 3.64 mg).
Hver ml indeholder 100 enheder insulin glulisin (svarende til 3,49 mg).
Each ml contains 100 Units insulin glulisine (equivalent to 3.49 mg).
Hver ml indeholder 100 internationale enheder humant insulin.
Each ml contains 100 international units of human insulin.
Hver ml indeholder 100 mg levetiracetam.
Each ml contains 100 mg levetiracetam.
Hver ml indeholder 100 mg levetiracetam.
Each ml oral solution contains 100 mg levetiracetam.
Hver ml indeholder 100 mikrogram ziconotid (som acetat)
Each ml contains 100 micrograms ziconotide (as acetate).
Hver ml indeholder 11,6-12,9 mg natrium.
Each ml contains 11.6-12.9 mg sodium.
Hver ml indeholder 12 mg oseltamivir.
Each ml of suspension contains 12 mg oseltamivir.
Hver ml indeholder 150 mg indoxacarb og 480 mg permethrin.
Each ml contains 150 mg indoxacarb and 480 mg permethrin.
Hver ml indeholder 2 mg idursulfase.
Each ml contains 2 mg of idursulfase
Hver ml indeholder 20 mg dexrazoxan efter rekonstitution med 25 ml Savene opløsningsvæske.
Each ml contains 20 mg of dexrazoxane after reconstitution with 25 ml of Savene diluent.
Hver ml indeholder 20 mg pregabalin
Each ml contains 20 mg pregabalin.
Hver ml indeholder 20 mg pregabalin.
Each ml contains 20 mg of pregabalin.
Hver ml indeholder 20 mg robenacoxib som aktivt stof og 1 mg natriummetabisulfit (E223) som antioxidant.
Each ml contains 20 mg robenacoxib as active substance and 1 mg sodium metabisulphite (E 223) as an antioxidant.
Hver ml indeholder 25 mg monepantel
Each ml contains 25 mg of monepantel
Hver ml indeholder 250 mikrogram teriparatid.
Each mL contains 250 micrograms of teriparatide.
Hver ml indeholder 3,81 mg natrium.
Each ml contains 3.81 mg sodium.
Hver ml indeholder 312 IE/ml humant hepatitis B-immunglobulin svarende til et proteinindhold på 30-70 mg/ml med mindst 96 % immunglobulin G (IgG).
Each ml contains 312 IU Human Hepatitis B Immunoglobulin corresponding to a protein content of 30-70 mg/ml with at least 96% Immunoglobulin G (IgG).
Hver ml indeholder 312 IE/ml humant hepatitis B-immunglobulin svarende til et proteinindhold på 30-70 mg/ml, hvoraf mindst 96 % er immunglobulin G (IgG).
Each ml contains 312 IU Human hepatitis B immunoglobulin, corresponding to a protein content of 30-70 mg/ml of which 96% is Immunoglobulin G (IgG).
Hver ml indeholder 4,28 mg propranololhydrochlorid ækvivalent med 3,75 ml propranolol.
Each ml contains4.28 mg of propranolol hydrochloride equivalent to 3.75 mg of propranolol.
Hver ml indeholder 40 IE human insulin (svarende til 1,4 mg).
Each ml contains 40 IU insulin human (equivalent to 1.4 mg) of the active substance.
Hver ml indeholder 40 internationale enheder humant insulin.
Each ml contains 40 international units of human insulin.
Hver ml indeholder 400 mikrogram glycopyrroniumbromid svarende til 320 mikrogram glycopyrronium.
Each ml contains 400 micrograms glycopyrronium bromide equivalent to 320 micrograms of glycopyrronium.
Hver ml indeholder 5 mg ibuprofen
Each ml contains 5 mg ibuprofen
Hver ml indeholder 50 mg d-alfa-tocopherol i form af tocofersolan svarerende til 74,5 IE tocopherol.
Each ml contains 50 mg of d-alpha-tocopherol, in the form of tocofersolan, corresponding to 74.5 IU of tocopherol.
Hver ml indeholder 500 mg.
Each ml contains 500 mg.
Hver ml indeholder 5000 E botulismetoksin type B
Each ml contains 5000 U Botulinum Toxin Type B.
Hver ml indeholder 5000 E botulismetoksin type B.
Each ml contains 5000 U of Botulinum Toxin Type B.
Hver ml indeholder 54 mg dinotefuran, 4.84 mg pyriproxyfen, og 397 mg permethrin.
Each ml contains 54 mg dinotefuran, 4.84 mg pyriproxyfen and 397 mg permethrin.
Hver ml indeholder 54 mg dinotefuran; 4,84 mg pyriproxyfen og 397 mg permethrin.
Each ml contains 54 mg dinotefuran, 4.84 mg pyriproxyfen and 397 mg permethrin.
Hver ml indeholder 60 millioner enheder (ME) (600 mikrogram) eller 96 millioner enheder (ME) (960 mikrogram) filgrastim.
Each ml contains 60 million units [MU] (600 micrograms) or 96 million units [MU] (960 micrograms) of filgrastim.
Hver ml indeholder 7,5 mg aripiprazol.
Each ml contains 7.5 mg aripiprazole.
Hver ml indeholder 7,5 mg aripiprazol.
Each ml contains 7.5 mg of aripiprazole.
Hver ml indeholder maksimalt 6,4 x 109 perflutrenholdige lipidmikrosfærer med en gennemsnitlig diameter på 1,1-2,5 mikrometer (µm).
Each ml contains a maximum of 6.4 x 109 perflutren-containing lipid microspheres, with a mean diameter range of 1.1-2.5 micrometres (µm).
Hver ml indeholder rivastigminhydrogentartrat, der svarer til 2 mg rivastigmin base.
Each ml contains rivastigmine hydrogen tartrate corresponding to rivastigmine base 2.0 mg.
Hver ml indeholder rivastigminhydrogentartrat, der svarer til 2,0 mg rivastigmin base.
Each ml contains rivastigmine hydrogen tartrate corresponding to rivastigmine base 2.0 mg.
Hver ml indeholder:
One ml contains:
Hver ml indeholder: 80 mg lopinavir og 20 mg ritonavir (farmakokinetisk forstærker).
Each ml contains lopinavir 80 mg and ritonavir 20 mg (pharmacokinetic enhancer).
Hver ml indeholder: 80 mg lopinavir og 20 mg ritonavir (farmakokinetisk forstærker).
Each ml contains: lopinavir 80 mg and ritonavir 20 mg (pharmacokinetic enhancer).
Hver ml indeholder: Meloxicam 0,5 mg
Each ml contains:
Hver ml indeholder: Meloxicam 5 mg
Each ml contains:
Hver ml infusionskoncentrat indeholder 0,150 mmol natrium svarende til 3,45 mg natrium.
Each mL of concentrate contains 0.150 mmol sodium, which is 3.45 mg sodium.
Hver ml infusionsvæske indeholder 7 mg natrium.
Each mL of reconstituted solution contains 7 mg of sodium.
Hver ml infusionsvæske, opløsning indeholder 2,99 mg natrium.
Each ml of solution for infusion contains includes 2.99 mg sodium.
Hver ml inhalationsvæske til nebulisator, opløsning indeholder levofloxacinhemihydrat svarende til 100 mg levofloxacin.
Each ml of nebuliser solution contains levofloxacin hemihydrate equivalent to 100 mg of levofloxacin.
Hver ml injektions- eller infusionsvæske indeholder 60 mio enheder [ME] (600 mikrogram) filgrastim*.
Each ml of solution for injection or infusion contains 60 million units [MU] (600 micrograms) of filgrastim*.
Hver ml injektions- eller infusionsvæske indeholder 96 mio enheder [ME] (960 mikrogram) filgrastim*.
Each ml of solution for injection or infusion contains 96 million units [MU] (960 micrograms) of filgrastim*.
Hver ml injektions-/infusionsvæske indeholder 50 mg sorbitol (E420).
Each ml of solution contains 50 mg sorbitol (E420).
Hver ml injektions-/infusionsvæske, opløsning indeholder 10 mg brivaracetam.
Each ml of solution for injection/infusion contains 10 mg brivaracetam.
Hver ml injektions-/infusionsvæske, opløsning indeholder 3,8 mg natrium.
Each ml of solution for injection/infusion contains includes 3.8 mg sodium.
Hver ml injektionsvæske indeholder:
One ml contains:
Hver ml injektionsvæske, opløsning indeholder 1.900 MBq florbetapir (18F) på datoen og tidspunktet for kalibrering (ToC).
Each mL of solution for injection contains 1900 MBq of florbetapir (18F) at the date and time of calibration (ToC).
Hver ml injektionsvæske, opløsning indeholder 1900 MBq florbetapir (18F) på datoen og tidspunktet for kalibrering (ToC).
Each mL of solution for injection contains 1900 MBq of florbetapir (18F) at date and time of calibration (ToC).
Hver ml injektionsvæske, opløsning indeholder 800 MBq florbetapir (18F) på datoen og tidspunktet for kalibrering (ToC).
Each mL of solution for injection contains 800 MBq of florbetapir (18F) at date and time of calibration (ToC).
Hver ml koncentrat indeholder 0,183 mmol natrium, hvilket svarer til 4,2 mg natrium.
Each ml of concentrate contains 0.183 mmol sodium, which is 4.2 mg of sodium.
Hver ml koncentrat indeholder 2 mg sebelipase alfa*.
Each ml of concentrate contains 2 mg sebelipase alfa*.
Hver ml koncentrat indeholder 20 mg docetaxel (vandfri).
Each ml of concentrate contains 20 mg docetaxel (anhydrous).
Hver ml koncentrat indeholder 20 mg docetaxel (vandfri).
Each ml of concentrate for solution for infusion contains 20 mg of docetaxel (anhydrous).
Hver ml koncentrat indeholder 20 mg docetaxel vandfri.
Each ml of concentrate contains 20 mg docetaxel anhydrous.
Hver ml koncentrat indeholder 20 mg docetaxel, vandfri.
Each ml of concentrate contains 20 mg docetaxel anhydrous.
Hver ml koncentrat indeholder 20 mg docetaxel.
Each ml of concentrate contains 20 mg docetaxel.
Hver ml koncentrat indeholder 20 mg panitumumab.
Each mL of concentrate contains 20 mg panitumumab.
Hver ml koncentrat indeholder 20 mg tocilizumab*.
Each ml concentrate contains 20 mg tocilizumab*.
Hver ml koncentrat indeholder 25 mg belatacept efter rekonstituering.
After reconstitution, each ml of concentrate contains 25 mg belatacept.
Hver ml koncentrat indeholder 5 mg ipilimumab.
Each ml of concentrate contains 5 mg ipilimumab.
Hver ml koncentrat indeholder dexmedetomidinehydrochlorid svarende til 100 mikrogram dexmedetomidin.
Each ml of concentrate contains dexmedetomidine hydrochloride equivalent to 100 micrograms dexmedetomidine.
Hver ml Norvir indeholder 80 mg ritonavir.
Each ml of Norvir contains 80 mg ritonavir.
Hver ml opløsning indeholder (123I) 74 MBq ioflupan på referencetidspunktet for aktivitet (0,07 til 0,13 μg ioflupan/ml).
Each ml of solution contains ioflupane (123I) 74 MBq at reference time (0.07 to 0.13 μg/ml of ioflupane).
Hver ml opløsning indeholder 0,05 mg benzalkoniumchlorid.
Each ml of solution contains 0.05 mg of benzalkonium chloride.
Hver ml opløsning indeholder 0,194 mmol (svarende til 4,5 mg) natrium.
Each mL of solution contains 0.194 mmol (equivalent to 4.5 mg) of sodium.
Hver ml opløsning indeholder 1 mg elosulfase alfa*.
Each ml of solution contains 1 mg elosulfase alfa*.
Hver ml opløsning indeholder 1 mg galsulfase.
Each ml of solution contains 1 mg galsulfase.
Hver ml opløsning indeholder 1,3 GBq samarium (153Sm) lexidronam pentanatrium på referencedato. (svarende til 20 til 80 µg/ml samarium pr. hætteglas)
Each ml of solution contains 1.3 GBq Samarium (153Sm) lexidronam pentasodium at the reference date (corresponding to 20 to 80 µg/ml of samarium per vial)
Hver ml opløsning indeholder 1,3 GBq samarium (153Sm) lexidronam pentanatrium på referencedato. (svarende til 20-80 µg/ml samarium pr. hætteglas).
Each ml of solution contains 1.3 GBq Samarium (153Sm) lexidronam pentasodium at the reference date (corresponding to 20-80 µg/ml of samarium per vial).
Hver ml opløsning indeholder 1.000 mikrogram fentanyl (som citrat)
Each ml of solution contains 1,000 micrograms fentanyl (as citrate)
Hver ml opløsning indeholder 1.000 mikrogram fentanyl (som citrat).
Each ml of solution contains 1,000 micrograms fentanyl (as citrate).
Hver ml opløsning indeholder 10 mg lipegfilgrastim.
Each ml of solution contains 10 mg lipegfilgrastim.
Hver ml opløsning indeholder 10.000 IE epoetin alfa*, svarende til 84,0 mikrogram per ml.
Each ml of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per ml
Hver ml opløsning indeholder 100 enheder (E) insulin degludec.
Each mL of solution contains 100 units (U) of insulin degludec.
Hver ml opløsning indeholder 150 mg canakinumab efter rekonstitution.
After reconstitution, each ml of solution contains 150 mg canakinumab.
Hver ml opløsning indeholder 150 mg lidocain og 50 mg prilocain
Each ml of solution contains 150 mg lidocaine and 50 mg prilocaine.
Hver ml opløsning indeholder 2 mg cladribine (2-CdA).
Each ml of solution contains 2 mg of cladribine (2-CdA).
Hver ml opløsning indeholder 2 mg cladribine.
Each ml solution contains 2 mg cladribine.
Hver ml opløsning indeholder 2 mg/ml eptifibatid.
Each ml of solution for injection contains 2 mg of eptifibatide.
Hver ml opløsning indeholder 2.000 IE epoetin alfa*, svarende til 16,8 mikrogram per ml.
Each ml of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per ml
Hver ml opløsning indeholder 2.000 IE epoetin alfa*, svarende til 16,8 mikrogram per ml.En fyldt injektionssprøjte med 0,5 ml indeholder 1.000 internationale enheder (IE), svarende til 8,4 mikrogram epoetin alfa.*
A pre-filled syringe of 0.5 ml contains 1,000 international units (IU) corresponding to 8.4 micrograms epoetin alfa.
Hver ml opløsning indeholder 4.000 mikrogram fentanyl (som citrat)
Each ml of solution contains 4,000 micrograms fentanyl (as citrate)
Hver ml opløsning indeholder 4.000 mikrogram fentanyl (som citrat).
Each ml of solution contains 4,000 micrograms fentanyl (as citrate).
Hver ml opløsning indeholder 400 mikrogram glycopyrroniumbromid svarende til 320 mikrogram glycopyrronium.
Each ml of solution contains 400 micrograms glycopyrronium bromide equivalent to 320 micrograms of glycopyrronium.
Hver ml opløsning indeholder 50 mikrogram palonosetron (som hydrochlorid).
Each ml of solution contains 50 micrograms of palonosetron (as hydrochloride).
Hver ml opløsning indeholder 60 millioner enheder (ME) (svarende til 600 mikrogram [μg]) filgrastim.
Each ml of solution contains 60 million units (MU) (equivalent to 600 micrograms [μg]) of filgrastim.
Hver ml opløsning indeholder 600 IE (svarende til 44 mikrogram) follitropin alfa*.
Each mL of the solution contains 600 IU (equivalent to 44 micrograms) follitropin alfa*.
Hver ml opløsning indeholder 600 IE (svarende til 44 µg) follitropin alfa*.
Each ml of the solution contains 600 IU (equivalent to 44 micrograms) of follitropin alfa*.
Hver ml opløsning indeholder 600 IE (svarende til 44 µg) follitropin alfa.
Each mL of the solution contains 600 IU (equivalent to 44 micrograms) follitropin alfa.
Hver ml opløsning indeholder 600 IE follitropin alfa* (svarende til 44 mikrogram).
Each mL of the solution contains 600 IU of follitropin alfa*, (equivalent to 44 micrograms).
Hver ml opløsning indeholder 600 IE, svarende til 44 µg.
Each ml of the solution contains 600 IU equivalent to 44 micrograms.
Hver ml opløsning indeholder ioflupan (123I) 74 MBq på referencetidspunktet for aktivitet (0,07 til 0,13 μg/ml ioflupan).
Each ml of solution contains ioflupane (123I) 74 MBq at reference time (0.07 to 0.13 μg/ml of ioflupane).
Hver ml opløsning til injektion eller infusion indeholder 60 millioner enheder [ME] (600 mikrogram) filgrastim*.
Each ml of solution for injection or infusion contains 60 million units [MU] (600 micrograms) of filgrastim*.